Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The patent portfolio for David Kroeger currently shows 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This 1 active matter is being handled by 1 distinct examiner, indicating a highly concentrated prosecution focus at this stage. The involvement of 1 distinct art unit suggests that the underlying subject matter remains within a specific regulatory or technical niche.
LISA V COOK is identified as the busiest examiner for this portfolio, currently managing the only active case. Because this examiner is responsible for the entirety of the pending workload, the prosecution timeline for the portfolio is directly tied to the specific throughput and procedural habits of this individual. Practitioners should monitor the examiner's history within the Biotechnology & Pharmaceuticals sector to anticipate potential hurdles or response requirements.
The alignment of the current workload with 1 distinct art unit simplifies the administrative tracking for this portfolio. This narrow distribution allows for a focused strategy when addressing the concerns raised by LISA V COOK, who is the busiest examiner pending 1 matter. By concentrating on the specific requirements of this art unit, the legal team can ensure that the technical arguments remain consistent throughout the prosecution process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COOK, LISA V | 1 | 67.6% | +9.9% |
| Art Unit | Apps |
|---|---|
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17787773 | COMPOSITIONS AND METHODS FOR OOCYTE-SPECIFIC CONTRACEPTION | COOK, LISA V | 1642 | §112 | Non-Final OA | — | Pending | Jun 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial